Drug
NX 1207
NX 1207: highest development phase Phase 3, developed by Recordati. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Recordati
Trials
| Drug | Phase | Indication |
|---|---|---|
| NX-1207 NCT02003742 | Phase 3 | Lower Urinary Tract Symptoms |
Latest
No recent events.
Follow NX 1207 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.